Abstract
High Sensitivity Simoa Immunoassays to Evaluate Levels of Postsynaptic density protein 95 and Neuronal Pentraxin II as Predictors of Cognitive Function Loss in Alzheimer’s Diseases (P3-3.004)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
